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It was the aim of this study to investigate possible modulating influences on gross behavior in 
doses of artesunate in wistar rats. Thirty-six healthy adult rats were placed into nine groups 
comprising of eight test groups and one control group.  Artesunate was prepared into different 
doses, and two test animals were administered with one of the doses following which they 
were observed together for various behavioral parameters for a period of one hour. The control 
group received no drug treatments, but were observed for behavioral activities after they were 
administered with 0.4ml of normal saline. All the behavioral data were pooled and subjected to 
statistical analysis using the One Way Anova with Dunnet multiple comparison post adhuc 
test. Results were expressed as Mean ±SEM, and P values of (p ≤0.05) regarded as statistically 
significant. Behavioral excitatory effects were observed at lower doses of artesunate in mainly 
grooming, rearing and feeding behaviors. Sedative effects were observed in locomotor, 
sniffing, climbing and scratching activities and these later effects were also seen at the lower 
doses of the drug. Meanwhile, sedative effects were seen in all the behavioral parameters at the 
higher doses. It was concluded that artesunate may have some clearly definable central nervous 
system properties. Specifically, it was noted that artesunate may have dual behavioral 
modulating properties of both excitatory and sedative effects in wistar rat.  It was concluded 
that the mechanism of action for these alterations in gross behavior may be closely linked with 
the neurotransmitter systems that normally regulate behavior in the central nervous system.                       





The level of melatonin drops significantly during 
puberty to allow for sexual maturation (Waldhauser et 
al., 1988; Karasek, 2007). A high melatonin level 
during this stage of life has been reported to delay 
sexual maturation, reduce gonadal development and 
thus prevent reproductive capacity (Rissman, 1980, 
Amador et al., 1986). Short photoperiod or long 
photoperiod with melatonin treatment has also been 
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reported to delay gonadal development in rodent 
populations (Zucker et. al. 1980, Deveson et al., 1992). 
The role chronic melatonin administration on 
reproductive function in pre-pubertal, young, middle-
aged and old mice and female rats has been 
documented (Pierpaoli et al., 1997; López et al., 2005). 
Gwayi and Bernard reported a dose dependent decrease 
in all parameters of sperm motility with melatonin 
treatment in vitro on spermatozoa collected from adult 
Wistar rats (Gwayi and Bernard, 2002). Melatonin 
treatment improved epididymal sperm concentration 
and motility in 6-7 months old homocysteine treated 
Wistar rats (Sönmez et al., 2007). However, the role of 
chronic treatment of melatonin in male reproductive 
function at old age in male Sprague Dawley rats 
remains an unanswered. This paper presents results 
from a comparative study on the outcome of melatonin 
administration on male reproductive function during 
ageing in Sprague Dawley rats.  
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Thirty six (36) Adult Wistar rats of comparable 
age, weight and size were kept in cages for about 
two weeks in the animal house of the department 
of pharmacology, University of Benin, Benin city, 
Nigeria, to acclimatize to the new environment 
before the commencement of the experiments. The 
animals had free access to standard feeds and 
water throughout the experiments. The animals 
were separated into nine groups by the use of body 
markings, with each group comprising of four rats. 
The control group received 0.4mls of normal 
saline, while the eight test groups received acute 
daily administration of the various doses (2, 4, 8, 
16, 32, 64, 128 and 250mg/kg) of artesunate 
solution, respectively, for the duration of the three 
weeks experiments. 
A standardized artesunate solution was made by 
dissolving known quantity in a measured quantity 
of normal saline, the mixture was left standing for 
30minutes thereafter it was sieved to remove the 
debris of starch and other coatings to obtain a 
solution of dissolved fresh artesunate solution, and 
which was prepared each experimental session 
(Klaus et al.,2011). 
The open field tests were conducted in standard 
wooden cages of 40cm x 40cm and of 20cm height 
of wall (Dubovicky et al., 2004; Verma et al., 
2009). The floor of the open field apparatus was 
designed after the method of Krishna et al.( 2001), 
and made up of four parts subdivisions of 10cm 
each, which allowed for clear viewing of the 
animals.  
The doses were administered intra-peritoneally 
(i/p), such that two rats of same sex received the 
same dose and were observed together for a period 
of one hour after the administration. Each of the 
behavioral parameter was scored manually by a 
tally counting method. After each observation 
period, the open field apparatus was cleaned using 
70% ethyl ethanol and allowed to dry before the 
next observation was conducted (Davies et al., 
2013). The behavioral parameters scored were 
Climbing, Scratching, Rearing, Grooming, 
Stereotyped movement, Sniffing, Feeding, 
Drinking, Aggression and Locomotor activity. 
The results of the behavioral activities were pooled 
and analyzed using the One Way Anova version 
5.0 with Dunnet Multiple Comparison post adhoc 
test (Lyvia et al., 2005). The behavioral data were 
expressed as mean and standard error of mean 
while P values of P≤0.05 were considered as 






 Fig.1:  
Sniffing, Scratching, Drinking, Feeding and Aggression 
activities in open fieldTest following the administration of 






Fig. 2:  
Locomotor, Climbing, Rearing, Stereotyped movement and 
Grooming activities in open field test after the administration 
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Table 1: Mean values of gross behavioral activities in acute administration of varying doses of artesunate in Wistar rats. 
 
*Significant values (*P≤0.05, ** P≤0.01, *** P≤0.001) are Mean ±SEM compared to control (n=4) 
 
 
Table 2: Mean values of some gross behavioral activities in acute doses of artesunate in Wistar rats.  
 
    *Significant values (*P≤0.05, ** P≤0.01 and *** P≤0.001) are Mean ±SEM compared to control (n=4) 
 
DISCUSSION  
The mean values of the behavioral data in Table 1 
revealed a clear decrease in sniffing and scratching 
activities (p ≤0.05) at lower test doses of artesunate. 
Decrease in locomotor and climbing activities were 
also seen at lower doses (Table 2). On the other hand, 
there was increase in feeding behavior, grooming and 
rearing activities (p ≤0.05) at lower doses (Tables 
1&2). Aggressive behavior was not seen throughout the 
experiments, and there was no definite change in 
drinking behavior throughout the various test doses 
(Table 1).                                                                        
In one similar study, aggressive behavior was also not 
observed in rats in acute doses of ascorbic acid 
(Ezenwanne and Anuka, 1991). The decrease in 
locomotor and climbing activities seen at lower doses 
(Table 2), were essentially at variance with the 
excitatory effects seen in the other behavioral 
parameters (feeding, grooming and rearing) at the same 
doses. This observation is suggestive that artesunate 
may have dual behavioral modulating effects in wistar 
rat.  Nonetheless, there were sedative effects in all the 
behavioral parameters at higher doses of the artesunate 
(Tables 1&2). Sedative effects on gross behavioral 
activities were also reported in rats administered with 
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ascorbic acid (Ezenwanne and Anuka, 1991). However 
these observations with ascorbic acid treated rats were 
based on treatments at high doses of the substance. The 
present observation is essentially in agreement with the 
work of Wambebe and Sokomba (1986) in which 
behavioral excitatory effects were also observed in rats 
treated with ascorbic acid. However, it is noteworthy 
that these are two different compound employed in the 
works of the different researchers.  
The open field test as was in the design of the present 
study, provides simultaneous measure of behavioral 
exploration and anxiety. It is possible to argue that 
artesunate possesses some clearly definable pharmaco-
behavioral properties in the central nervous system that 
accounts for the present observed modulating 
influences on gross behavior in rats. From the present 
study, it is possible that the mode of action of 
artesunate seen at low doses is linked to D1 and D2 
receptors activation through a mechanism similar to 
dopamine activation of D1 and D2 receptors as reported 
by komorowska and pellis (2004).  For example, Amos 
et al. (2003) successfully demonstrated that 
bromocriptine is a D2 receptor agonist that can induce 
locomotor activity in mice pretreated reserpine, a 
behavioral pattern  which was attenuated by artemisinin 
at high doses. The result was also suggestive that 
artemisinin may have sedative properties at high doses, 
which may be mediated via postsynaptic dopamine D2 
receptor in the central nervous system.  
The behavioral data in the present study show that 
locomotor, climbing, sniffing and scratching activities 
were the most profoundly depressed in the course of the 
administrations, while grooming and feeding were the 
more significantly activated (Figures 1&2).  However, 
it should be noted that novel environments have been 
reported to influence the behavioral pattern of animals 
(Moses et al., 2010), and this has been shown to be 
further complicated when substances that may modify 
the already altered behavior are taken by the animals 
(Brown et al., 2007). The open field test is a widely 
used novel environmental apparatus in behavioral 
testing in wistar rats, and records of data show wider 
range of alterations in level of exploratory abilities and 
anxiety of the rat (Adjene and Ezenwanne, 2008). 
 
CONCLUSION  
It was concluded that artesunate may have some clearly 
definable central nervous system properties as evident 
from the modulating influences on gross behavioral 
activities observed in this study. The mechanism of 
action for these effects may be closely linked with the 
neurotransmitter systems known to normally regulate 
various forms of behavior. 
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